JP2015510758A5 - - Google Patents

Download PDF

Info

Publication number
JP2015510758A5
JP2015510758A5 JP2014560516A JP2014560516A JP2015510758A5 JP 2015510758 A5 JP2015510758 A5 JP 2015510758A5 JP 2014560516 A JP2014560516 A JP 2014560516A JP 2014560516 A JP2014560516 A JP 2014560516A JP 2015510758 A5 JP2015510758 A5 JP 2015510758A5
Authority
JP
Japan
Prior art keywords
cell
cells
apoptosis
cell population
inducing ligand
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014560516A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015510758A (ja
JP6429191B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IL2013/000026 external-priority patent/WO2013132477A1/en
Publication of JP2015510758A publication Critical patent/JP2015510758A/ja
Publication of JP2015510758A5 publication Critical patent/JP2015510758A5/ja
Application granted granted Critical
Publication of JP6429191B2 publication Critical patent/JP6429191B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014560516A 2012-03-06 2013-03-05 アポトーシスシグナル伝達抵抗性細胞を選択する装置および方法ならびにその使用 Expired - Fee Related JP6429191B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261607033P 2012-03-06 2012-03-06
PCT/IL2013/000026 WO2013132477A1 (en) 2012-03-06 2013-03-05 Devices and methods for selecting apoptosis-signaling resistant cells, and uses thereof

Publications (3)

Publication Number Publication Date
JP2015510758A JP2015510758A (ja) 2015-04-13
JP2015510758A5 true JP2015510758A5 (enExample) 2016-04-21
JP6429191B2 JP6429191B2 (ja) 2018-11-28

Family

ID=49116028

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014560516A Expired - Fee Related JP6429191B2 (ja) 2012-03-06 2013-03-05 アポトーシスシグナル伝達抵抗性細胞を選択する装置および方法ならびにその使用

Country Status (11)

Country Link
US (2) US9783778B2 (enExample)
EP (2) EP2823040B1 (enExample)
JP (1) JP6429191B2 (enExample)
KR (1) KR101912982B1 (enExample)
CN (2) CN104245924B (enExample)
AU (1) AU2013229008B2 (enExample)
CA (1) CA2866358C (enExample)
DK (1) DK2823040T3 (enExample)
IL (1) IL234459B (enExample)
RU (1) RU2630301C2 (enExample)
WO (1) WO2013132477A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2016116732A (ru) * 2013-10-09 2017-11-15 Сэллект Байотерапьютикс Лтд. Активация гемопоэтических клеток-предшественников путем предтрансплантационного воздействия лигандами рецепторов смерти
WO2016193986A2 (en) 2015-06-05 2016-12-08 Cellect Biotherapeutics Ltd. Selective surfaces for, and methods of, selecting a population of stem and progenitor cells, and uses thereof
JP2021534747A (ja) * 2018-08-22 2021-12-16 セレクト バイオセラピューティクス リミテッド アポトーシス感受性細胞のモジュレーション
US20220002363A1 (en) * 2020-07-03 2022-01-06 United States Government As Represented By The Department Of Veterans Affairs Compositions and methods for treating pulmonary disease

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
JPS61235752A (ja) 1985-04-11 1986-10-21 Asahi Optical Co Ltd 細胞分離材、分離器および分離方法
IT8523298V0 (it) * 1985-10-02 1985-10-02 Pierrel Hospital Spa Catetere venoso centrale.
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
US4979959A (en) 1986-10-17 1990-12-25 Bio-Metric Systems, Inc. Biocompatible coating for solid surfaces
US4885234A (en) 1988-09-29 1989-12-05 Eastman Kodak Company Photographic materials containing stable cyan coupler formulations
US5998024A (en) 1995-02-02 1999-12-07 Rainer H. Frey Biocompatible material and method of manufacture and use thereof
EA002819B1 (ru) 1997-05-14 2002-10-31 Авентис Фармасьютикалз Продактс Инк. Циклическое пептидное соединение и его применение, бициклопептидное соединение, пептидное соединение и его применение, фармацевтическая композиция
US6040182A (en) 1997-11-12 2000-03-21 Becton Dickinson And Company Method and materials for efficiency protein immobilization on tissue culture treated assay plates
GB9724270D0 (en) 1997-11-17 1998-01-14 Babraham The Inst Methods and means for mutagenesis of dna
EP1076635B1 (en) 1998-04-22 2002-03-06 St. Jude Medical AB Biocompatible material for implants
US20010049115A1 (en) * 2000-01-17 2001-12-06 Collins John Kevin Vitro model for gastrointestinal inflammation
US20090130718A1 (en) 1999-02-04 2009-05-21 Diversa Corporation Gene site saturation mutagenesis
US20030119185A1 (en) * 2000-02-24 2003-06-26 Xcyte Therapies, Inc. Activation and expansion of cells
WO2003002761A1 (en) 2001-06-29 2003-01-09 Novozymes A/S Method of multimerization and site-directed mutagenesis
US20030044389A1 (en) 2001-07-02 2003-03-06 Brown Patrick O. Microarrays for cell phenotyping and manipulation
EP1281767A3 (en) 2001-07-31 2003-05-28 Aladar A. Szalay Light emitting microorganisms and cells for diagnosis and therapy of tumors
DE10144252A1 (de) * 2001-08-31 2003-03-27 Fraunhofer Ges Forschung Nanopartikel mit daran immobilisiertem biologisch aktivem TNF
ATE519115T1 (de) * 2002-06-13 2011-08-15 Merck Patent Gmbh Verfahren für die identifizierung von allo- antigenen und ihre verwendung für krebstherapie und transplantation
US20040115216A1 (en) * 2002-07-12 2004-06-17 The Johns Hopkins University Reagents and methods for engaging unique clonotypic lymphocyte receptors
US20060009623A1 (en) 2004-07-06 2006-01-12 National University Of Singapore C-terminal attachment of ligands to proteins for immobilization onto a support
US20080241109A1 (en) * 2004-10-01 2008-10-02 Marc Dupuis Method for Ex-Vivo Purging in Autologous Transplantation
US8252587B2 (en) * 2004-10-25 2012-08-28 Celerant Therapeutics, Inc. Methods of expanding myeloid cell populations and uses thereof
DE602005008265D1 (de) * 2005-12-23 2008-08-28 Biedermann Motech Gmbh Flexible Stabilisierungsvorrichtung zur dynamischen Stabilisierung von Knochen oder Wirbeln
CA2653881C (en) * 2006-05-31 2016-08-23 Styx Llc Methods of selecting stem cells and uses thereof
CN101517070A (zh) * 2006-05-31 2009-08-26 Styx有限责任公司 选择干细胞的方法及其用途
AU2008229636B2 (en) * 2007-03-16 2014-08-14 Qiagen Sciences Llc A cell-mediated immune response assay and kits therefor
KR100920729B1 (ko) 2007-10-01 2009-10-07 한국생명공학연구원 펩타이드 혼성체를 사용한 배향성이 조절된 항체단분자막의 제조방법
WO2009154840A2 (en) 2008-03-27 2009-12-23 Neostem, Inc. Compositions and methods using stem cells in cutaneous wound healing
JP2011522515A (ja) * 2008-04-10 2011-08-04 マサチューセッツ インスティテュート オブ テクノロジー 癌幹細胞を標的とする薬剤を同定する方法およびその使用
EP2282786B1 (en) 2008-06-13 2015-10-28 Smith & Nephew, Inc. Fixation devices for tissue repair
WO2010051032A1 (en) * 2008-10-31 2010-05-06 Synthes Usa, Llc Method and device for activating stem cells
GB0823553D0 (en) 2008-12-24 2009-01-28 Immunosolv Ltd Cell separation technique
JP5327457B2 (ja) * 2009-03-27 2013-10-30 セイコーエプソン株式会社 がん細胞分離装置およびその製造方法
JP2010227313A (ja) * 2009-03-27 2010-10-14 Seiko Epson Corp がん細胞除去システムおよびがん細胞除去装置
EP2595637B1 (en) * 2010-07-22 2017-11-01 Cellect Biotherapeutics Ltd. Regulatory immune cells with enhanced targeted cell death effect

Similar Documents

Publication Publication Date Title
Yang et al. Organoids: The current status and biomedical applications
Seyfried et al. Macrophages orchestrate hematopoietic programs and regulate HSC function during inflammatory stress
Flores-Guzmán et al. Concise review: ex vivo expansion of cord blood-derived hematopoietic stem and progenitor cells: basic principles, experimental approaches, and impact in regenerative medicine
AU2010362087B2 (en) Cell culture insert
Jeon et al. Generation of multilayered 3D structures of HepG2 cells using a bio-printing technique
Rajoriya et al. Gamma delta T-lymphocytes in hepatitis C and chronic liver disease
JP2021511790A5 (enExample)
Roato et al. Cancer stem cells, bone and tumor microenvironment: key players in bone metastases
Baek et al. Ex vivo expansion of natural killer cells using cryopreserved irradiated feeder cells
Bröker et al. Mass production of highly active NK cells for cancer immunotherapy in a GMP conform perfusion bioreactor
Mousavi et al. Expansion of human cord blood hematopoietic stem/progenitor cells in three-dimensional Nanoscaffold coated with Fibronectin
Li et al. Characteristics of CD8+ and CD4+ tissue‐resident memory lymphocytes in the gastrointestinal tract
Landwehr-Kenzel et al. Ex vivo expanded natural regulatory T cells from patients with end-stage renal disease or kidney transplantation are useful for autologous cell therapy
Balderman et al. Biology of BM failure syndromes: role of microenvironment and niches
Schliesser et al. Generation of highly effective and stable murine alloreactive T reg cells by combined anti‐CD 4 m A b, TGF‐β, and RA treatment
Schlieer et al. Tregs: application for solid-organ transplantation
Haniuda et al. In vitro-induced germinal center B cell culture system
Blau Bone marrow stromal cells in the pathogenesis of acute myeloid leukemia
Zhang et al. Current trends and research topics regarding intestinal organoids: an overview based on bibliometrics
Forte et al. The “vesicular intelligence” strategy of blood cancers
Gong et al. Advances, challenges and future applications of liver organoids in experimental regenerative medicine
Schirrmacher Cancer-reactive memory T cells from bone marrow: Spontaneous induction and therapeutic potential
EP4446402A3 (en) Improved culture methods and devices for testing
RU2014138001A (ru) Устройства и способы для отбора клеток, устойчивых к апоптотическим сигналам, и области их применения
JP2012000097A (ja) 組織幹細胞の増殖方法、およびそれより得られる組織幹細胞